Polfa Tarchomin
CEP Certificates (EDQM COS List)

Polfa Tarchomin

CEP Database

Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.

Chemical Poland
  • Total Records 1
  • Latest End Date 2009-04-07
  • Data Source EDQM
  • Last Updated 2004-10-01
Company Overview

Company

Polfa Tarchomin

Country

Poland

Social Profiles

Company Snapshot

Polfa Tarchomin

A. Fleminga 2 street, 03-176 Warsaw

Poland

www.polfa-tarchomin.com.pl/en/home/ info@tzf.pl View on Map
CEP Records Timeline (1 record)
2004
01 Oct
Chemical Expired

Product

Erythromycin

Substance

"Polfa" Tarchomin SA Warsaw PL

Certificate No.

R0-CEP 2001-319 - Rev 01

Substance No.

179

Issue Date

2004-10-01

End Date

2009-04-07

Country

Poland

Identifiers

Certificate No.: R0-CEP 2001-319 - Rev 01
Substance No.: 179

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    1 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
Official Source

All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).

Visit EDQM
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Country

Poland

Identifiers

Certificate No.: R0-CEP 2001-319 - Rev 01
Substance No.: 179

100% Official Data

Directly from the EDQM CEP database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

CEP data is obtained from the official EDQM (European Directorate for the Quality of Medicines) database.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.